GSA Capital Partners’s Sana Biotechnology SANA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $280K | Buy |
+102,458
| New | +$280K | 0.02% | 1301 |
|
|
2024
Q3 | – | Sell |
-184,728
| Closed | -$1.01M | – | 1964 |
|
|
2024
Q2 | $1.01M | Buy |
184,728
+148,520
| +410% | +$811K | 0.07% | 495 |
|
|
2024
Q1 | $362K | Sell |
36,208
-132,763
| -79% | -$1.33M | 0.03% | 1097 |
|
|
2023
Q4 | $689K | Sell |
168,971
-371,279
| -69% | -$1.51M | 0.06% | 598 |
|
|
2023
Q3 | $2.09M | Buy |
+540,250
| New | +$2.09M | 0.18% | 100 |
|
|
2023
Q2 | – | Sell |
-265,372
| Closed | -$868K | – | 1894 |
|
|
2023
Q1 | $868K | Sell |
265,372
-62,421
| -19% | -$204K | 0.09% | 396 |
|
|
2022
Q4 | $1.3M | Buy |
327,793
+130,816
| +66% | +$517K | 0.16% | 104 |
|
|
2022
Q3 | $1.18M | Buy |
196,977
+101,667
| +107% | +$610K | 0.16% | 102 |
|
|
2022
Q2 | $613K | Sell |
95,310
-40,795
| -30% | -$262K | 0.09% | 375 |
|
|
2022
Q1 | $1.12M | Buy |
+136,105
| New | +$1.12M | 0.15% | 138 |
|